跳转至内容
Merck
CN

420174

顺-3-羟基-DL-脯氨酸

95%

别名:

(±)-顺式-3-羟基吡咯烷-2-羧酸

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C5H9NO3
化学文摘社编号:
分子量:
131.13
PubChem Substance ID:
UNSPSC Code:
12352200
Beilstein/REAXYS Number:
4130229
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

SMILES string

O[C@@H]1CCN[C@@H]1C(O)=O

InChI

1S/C5H9NO3/c7-3-1-2-6-4(3)5(8)9/h3-4,6-7H,1-2H2,(H,8,9)/t3-,4+/m1/s1

InChI key

BJBUEDPLEOHJGE-DMTCNVIQSA-N

assay

95%

reaction suitability

reaction type: solution phase peptide synthesis

application(s)

peptide synthesis

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Sanjay Morzaria et al.
The Journal of otolaryngology, 34(5), 297-303 (2005-09-27)
To develop an evidence-based algorithm for determining the etiology of bilateral sensorineural hearing loss (SNHL) in a child. The frequency of different etiologies was previously determined. A systematic review of the literature for articles published between 1940 and January 2003
Identification of 3-hydroxyproline residues in several proteins of Fasciola hepatica.
S E Bozas et al.
Experimental parasitology, 82(1), 69-72 (1996-01-01)
Improved method for the evaluation of 3-hydroxyproline and 4-hydroxyproline in the urine.
G Bellon et al.
Journal of chromatography, 230(2), 420-426 (1982-07-09)
Mary Ann Weis et al.
The Journal of biological chemistry, 285(4), 2580-2590 (2009-11-27)
Collagen triple helices are stabilized by 4-hydroxyproline residues. No function is known for the much less common 3-hydroxyproline (3Hyp), although genetic defects inhibiting its formation cause recessive osteogenesis imperfecta. To help understand the pathogenesis, we used mass spectrometry to identify
P Wiedemann
Fortschritte der Ophthalmologie : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 86(2), 115-120 (1989-01-01)
The steps in the formal pathogenesis of proliferative vitreoretinopathy (inflammation, proliferation, the synthesis of extracellular matrix, and contraction) provide the target points for medical treatment. A survey of the relevant drugs is given. Anti-inflammatory agents (steroids, heparin) and antiproliferative agents

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持